| 292 |
Clotrimazole
|
-
Clotrimazole, CAS-RN: 23593-75-1, DTXSID7029871
|
None
|
| 511 |
Colcemid
|
-
Colcemid, CAS-RN: 477-30-5, DTXSID7020342
|
None
|
| 510 |
colchemid
|
|
None
|
| 124 |
Colchicine
|
-
Colchicine, CAS-RN: 64-86-8, DTXSID5024845
|
106: Chemical binding to tubulin in oocytes leading to aneuploid offspring
|
| 332 |
Colistin
|
-
Colistin, CAS-RN: 1066-17-7, DTXSID1040663
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 196 |
coumachlor
|
-
Coumachlor, CAS-RN: 81-82-3, DTXSID8041797
|
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 197 |
coumatetralyl
|
-
Coumatetralyl, CAS-RN: 5836-29-3, DTXSID8041799
|
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 527 |
COVID-19
|
|
None
|
| 612 |
curcumin
|
-
Curcumin, CAS-RN: 458-37-7, DTXSID8031077
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 244 |
Cyasterone
|
|
4: Ecdysone receptor agonism leading to incomplete ecdysis associated mortality
|
| 689 |
Cycloate
|
-
Cycloate, CAS-RN: 1134-23-2, DTXSID6032356
|
None
|
| 748 |
Cyclopamine
|
-
Cyclopamine, CAS-RN: 4449-51-8, DTXSID6043709
|
460: Antagonism of Smoothened receptor leading to orofacial clefting
|
| 774 |
Cyclophosphamide
|
-
Cyclophosphamide, CAS-RN: 50-18-0, DTXSID5020364
|
532: CYP450 upregulation leads to Chronic kidney disease
|
| 294 |
Cyclosporin
|
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|
| 776 |
Cyclosporin A
|
-
Cyclosporin A, CAS-RN: 59865-13-3, DTXSID0020365
|
None
|
| 591 |
Cyclosporin, FK506, Basiliximab, PFOA (perfluorooctanoic acid)
|
|
None
|
| 108 |
Cyfluthrin
|
-
Cyfluthrin, CAS-RN: 68359-37-5, DTXSID5035957
|
None
|
| 135 |
Cyp2f2 substrates
|
|
None
|
| 103 |
Cypermethrin
|
-
Cypermethrin, CAS-RN: 52315-07-8, DTXSID1023998
|
None
|
| 560 |
Cyproterone acetate
|
-
Cyproterone acetate, CAS-RN: 427-51-0, DTXSID5020366
|
None
|
| 484 |
D-2-hydroxyglutarate
|
|
None
|
| 121 |
D-limonene
|
-
D-Limonene, CAS-RN: 5989-27-5, DTXSID1020778
|
None
|
| 75 |
Daidzein
|
-
7,4'-Dihydroxyisoflavone, CAS-RN: 486-66-8, DTXSID9022310
|
None
|
| 631 |
Danger Associated Molecular Patters (DAMPs)
|
|
377: Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
|
| 312 |
Dazornet
|
|
242: Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity
|